Twin-to-twin transfusion syndrome (TTTS) is a rare, life-threatening complication of pregnancy that occurs in identical twins who share a single placenta. A recent medical intervention performed at King’s College Hospital in London successfully treated the condition in utero, saving the lives of identical twins. The procedure, known as fetoscopic laser ablation, corrects blood flow imbalances by sealing off abnormal blood vessel connections between the twins.
Understanding Twin-to-Twin Transfusion Syndrome
TTTS affects approximately 10% to 15% of identical twins who share a placenta, a condition medically defined as monochorionic twins. According to the Fetal Medicine Foundation, the condition develops when blood vessels within the shared placenta are unevenly distributed.
This imbalance causes one twin—the "donor"—to pump blood to the other twin, the "recipient," at an unequal rate. The donor twin experiences reduced blood volume, which can lead to restricted growth and low amniotic fluid levels. Conversely, the recipient twin receives too much blood, putting significant strain on their heart and increasing the risk of heart failure. Without medical intervention, severe cases of TTTS carry a high mortality rate for both fetuses.
The Role of Fetoscopic Laser Ablation
The standard of care for severe TTTS is fetoscopic laser ablation. During this procedure, surgeons insert a thin, fiber-optic endoscope into the uterus. Guided by ultrasound, they identify the abnormal vascular connections on the surface of the placenta.
A laser is then used to coagulate and seal these vessels, effectively partitioning the placenta so that each twin receives an independent blood supply. By stopping the unequal exchange of blood, the procedure allows the fetuses to stabilize and continue developing. According to research published in the journal The Lancet, this intervention significantly improves survival rates compared to traditional amnioreduction, which only drains excess fluid from the recipient twin without addressing the underlying vascular cause.
Clinical Outcomes and Monitoring
Following successful laser surgery, patients require intensive monitoring to ensure both twins remain stable. The primary goal of the surgery is to halt the progression of the syndrome and prevent preterm birth.
While the surgery is highly effective, it is a complex procedure performed by specialized fetal medicine teams. Potential risks include premature rupture of membranes and preterm labor. According to the NHS, ongoing ultrasound surveillance is critical in the weeks following the operation to track fetal growth and cardiac function. In successful cases, the surgery allows the pregnancy to progress toward a safer gestational age for delivery, significantly reducing the long-term neurological and physical risks associated with severe TTTS.
Frequently Asked Questions
What causes TTTS?
TTTS is not caused by anything the mother does. It is a random event occurring in monochorionic pregnancies where abnormal blood vessel connections in the shared placenta lead to an unequal sharing of blood.
How is the condition diagnosed?
Diagnosis is typically made through routine prenatal ultrasound scans. Doctors look for significant differences in amniotic fluid levels between the two twins and signs of cardiac strain in the recipient twin.
Is laser surgery the only option?
For mild cases, doctors may monitor the pregnancy closely. However, for severe or rapidly progressing TTTS, fetoscopic laser ablation is the gold-standard treatment to prevent fetal loss.